Delandre, O.; Gendrot, M.; Jardot, P.; Le Bideau, M.; Boxberger, M.; Boschi, C.; Fonta, I.; Mosnier, J.; Hutter, S.; Levasseur, A.;
et al. Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants. Pharmaceuticals 2022, 15, 445.
https://doi.org/10.3390/ph15040445
AMA Style
Delandre O, Gendrot M, Jardot P, Le Bideau M, Boxberger M, Boschi C, Fonta I, Mosnier J, Hutter S, Levasseur A,
et al. Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants. Pharmaceuticals. 2022; 15(4):445.
https://doi.org/10.3390/ph15040445
Chicago/Turabian Style
Delandre, Océane, Mathieu Gendrot, Priscilla Jardot, Marion Le Bideau, Manon Boxberger, Céline Boschi, Isabelle Fonta, Joel Mosnier, Sébastien Hutter, Anthony Levasseur,
and et al. 2022. "Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants" Pharmaceuticals 15, no. 4: 445.
https://doi.org/10.3390/ph15040445
APA Style
Delandre, O., Gendrot, M., Jardot, P., Le Bideau, M., Boxberger, M., Boschi, C., Fonta, I., Mosnier, J., Hutter, S., Levasseur, A., La Scola, B., & Pradines, B.
(2022). Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants. Pharmaceuticals, 15(4), 445.
https://doi.org/10.3390/ph15040445